Abstract: Background: The incidence of hyperbilirubinemia after off-pump coronary artery bypass grafting (OPCAB) is unclear. This study aimed at retrospectively analyzing the incidence and character of perioperative hyperbilirubinemia in patients undergoing OPCAB, to analyze the independent risk factors, to identify the correlation with adverse events and mortality, and to explore the management strategy of perioperative hyperbilirubinemia.Methods: Clinical data for 416 patients (314 males and 102 female), who had been subjected to off-pump coronary artery bypass grafting in the Department of Cardiac Surgery, Beijing Chaoyang Hospital from December, 2016 to March, 2019 were recorded. Hyperbilirubinemia was defined as serum total bilirubin ≥ 34.2 μmol/L within 5 days after surgery. Based on the occurrence of hyperbilirubinemia, patients were divided into the normal serum total bilirubin group and the hyperbilirubinemia group. Perioperative variables between the two groups were compared by univariate logistic regression analysis. Multivariate logistic regression analysis was used to analyze variables with statistical significance. Then, we determined the independent risk factors for hyperbilirubinemia after OPCAB. Moreover, incidences of adverse events, length of ICU stay, time of mechanical ventilation and mortality rates between the two groups were compared. Results: Thirty two of 416 patients were found to exhibit postoperative hyperbilirubinemia. The incidence rate was 7.7%. Based on univariate regresssion analysis, differences in gender, preoperative total bilirubin levels, perioperative IABP implantation, perioperative blood transfusion between the two groups were significant. Multivariate logistic regression analysis revealed that elevated preoperative serum total bilirubin levels (OR=1.241, p<0.001), perioperative blood transfusion (OR=0.237, p=0.002) and perioperative IABP implantation (OR=0.238, p=0.003) were independent risk factors for hyperbilirubinemia after OPCAB. Compared to the normal bilirubin group, incidences of new acute renal failure, continuous renal replacement therapy, perioperative myocardial infarction, pulmonary infection, multiple organ dysfunction syndrome and in-hospital mortality in the hyperbilirubinemia group were significantly increased.Conclusions: Perioperative hyperbilirubinemia is associated with adverse events and mortality. In clinical practice, changes in serum total bilirubin levels among patients undergoing OPCAB should be routinely monitored, and active as well as early interventions in patients with risk factors performed. In this manner, postoperative complications can be reduced, thereby improving patient prognosis.

The Etiology and Management of Early Postoperative Hyperbilirubinemia after Liver Transplantation

Etiology of Early Postoperative Hyperbilirubinemia after Liver Transplantation

Clinical Research on Early Post-Operative Hyperbilirubinemia after Liver Transplantation

The etiology and management of postoperative hyperbilirubinemia after orthotopic liver transplantation]

Causes and Treatment of Early Postoperative Hyperbilirubinemia after Liver Transplantation

Persistent Hyperbilirubinemia in Follow-Up Patients after Liver Transplantation

Regularity of Early Postoperative Bilirubin Changes after Adult Liver Transplantation

Frequency, risk factors, and prognosis of hyperbilirubinemia after cardiac surgery

Prediction Factors of Postoperative Hyperbilirubinemia in Living Right Lobe Donor: A Single-Center Analysis of 210 Cases

Risk Factors and Clinical Prognosis of Hyperbilirubinemia After Off-pump Coronary Artery Bypass Grafting

Clinical analysis of hyperbilirubinemia after heart surgery

The Liver Function Changes and Risk Factor Analysis in Patients at Peri-operative Period of Cardiopulmonary Bypass Surgery

Value of Analysis of Bilirubin in Bile in Predicting Liver Function in Early Stage after Liver Transplantation

The Impact of Perioperative Bilirubin and Albumin Levels on Postoperative Early Complications in Adult Liver Transplantation

Risk factor analysis and management of massive perihepatic blood accumulation after liver transplantation

Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication

[Evaluation of the Changes of HBV Serum Markers and HBV DNA and the Effects of Perioperative Factors after Liver Transplantation].

Efficacy And Safety Of Steroid Therapy For Posttransplant Hyperbilirubinemia Caused By Early Allograft Dysfunction: A Randomized Controlled Trial

Prevention of Biliary Complications after Liver Transplantation

Understanding of the Prevention and Tre Atment of Biliary Complications after Orthotopic Liver Transplantation

Analysis of the etiology,diagnosis and management of 8 cases of hepatic hilar biliary stricture following orthotopic liver transplantation